INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 465
08/07/2016
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Borses de viatge
Termini exhaurit
FEBS - FEDERATION OF EUROPEAN BIOCHEMICAL SOCIETIES
 
Termini exhaurit
FEBS - FEDERATION OF EUROPEAN BIOCHEMICAL SOCIETIES
 
Premis
Termini exhaurit
FUNDACIÓ SANTIAGO DEXEUS
PREMI concedit a la persona, persones, equip de treball o institució amb una trajectòria professional o línia de recerca continuada la qual representi una contribució rellevant en el camp de les Ciències de la Salut, especialment referides a la dona i particularment en l'àmbit de l'Obstetrícia, la Ginecologia i la Medicina de la Reproducció. Àmbit Internacional.
 
Termini exhaurit
ATRESMEDIA
Potenciar la recerca mèdica de qualitat i la prevenció en salut, a través d'iniciatives de sensibilització i d'accions concretes que impulsin avanços en l'àmbit biomèdic i científic
 
Termini exhaurit
AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
The award is given to an individual whose leadership and extraordinary achievements in cancer research or in support of cancer research have made a major impact on the field. Such achievements include contributions to the acceleration of progress in cancer research, raising national or international awareness of cancer research, or other demonstrations of a sustained commitment to the conquest of cancer.
 
Termini exhaurit
FPdGI - FUNDACIÓ PRINCESA DE GIRONA
Dirigida a premiar la trajectòria de joves científics (incloent de les ciències humanes i socials) amb experiències o projectes d'investigació destacats en la seva disciplina, emprenedors, innovadors i amb un elevat potencial de desenvolupament futur.
 
Recursos Humans
Termini exhaurit
FUNDACIÓ SANTIAGO DEXEUS
Convocatòria nacional de cinc beques d'investigació en els camps de:
  • Ginecologia general
  • Medicina materno fetal
  • Ginecologia oncològica
  • Medicina de la reproducció
  • Investigació bàsica en l'àmbit de l'obstetrícia i la ginecologia.
    		•
     
    Termini exhaurit
    EUROPEAN MOLECULAR BIOLOGY LABORATORY
    The EIPOD programme underlines EMBL’s strong commitment to promoting interdisciplinary research. The institution has a long-standing tradition of scientific excellence that builds on highly interactive research between the group leaders of different research units. EIPOD projects capitalise on synergies emerging at the borders of overlapping yet separate scientific fields, and involve transferring techniques to a novel context. The programme is open to all nationalities and offers about 20 positions annually.
     
     
     
    Informació últil
     
     
     
    Banner-convocatories-tancament-02
    Projectes
    Termini exhaurit
    INNOVATIVE MEDICINES INITIATIVE
    IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
    The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
     
    Termini exhaurit
    FJL - FONDATION JEROME LEJEUNE
    The main target of the Fondation Jerome Lejeune, a non profit foundation, is research into genetic diseases with intellectual disability.
     
    Termini exhaurit
    ALZHEIMER'S DRUG DISCOVERY FOUNDATION
    The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer's disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation.
     
    Termini exhaurit
    SOCIEDAD ESPAÑOLA DE NEUROLOGIA
    Beca dirigida a neuròlegs amb trajectòria de recerca acreditada, per a projectes de recerca en Neurosonologia que no comptin amb finançament de tercers.
     
    Termini exhaurit
    EUROPEAN HEMATOLOGY ASSOCIATION
    The European Hematology Association (EHA) promotes excellence in patient care, research and education in hematology.
    EHA will consider applications on any aspect of the study of hematology in its broadest sense including all subspecialties and including but not limited to molecular biology and biochemistry, virology, immunology, cell biology, epidemiology and diagnostic and therapeutic strategies.
     
    Altres
    Termini exhaurit
    BIOCAT - FUNDACIÓ PRIVADA BIOREGIÓ DE CATALUNYA
    Impulsar trobades internacionals d’alt nivell científic per promoure la col·laboració i l’intercanvi d’iniciatives i coneixements entre experts de reconegut prestigi i la comunitat científica catalana, generant debat avançat transversal en l’àmbit de les ciències de la vida i la seva repercussió a la societat.
     
    Termini exhaurit
    AVHF - ALEXANDER VON HUMBOLDT FOUNDATION
    The Alexander von Humboldt Foundation’s Sofja Kovalevskaja Award is granted to young exceptionally promising researchers from abroad in recognition of outstanding academic achievements. The award is designed to enable them to embark on academic careers in Germany by establishing their own junior research groups at research institutions in Germany.
    The programme is open to scientists and scholars from all countries and disciplines who completed their doctorates with distinction less than six years ago. The Alexander von Humboldt Foundation particularly welcomes applications from qualified, female junior researchers.
     
    Borses de viatge
    Termini exhaurit
    EUROPEAN RESPIRATORY SOCIETY
    ERS is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.
     
    Premis
    Termini exhaurit
    SCILIFELAB - SCIENCE FOR LIFE LABORATORY
    In order to promote young scientists early in their career, SciLifeLab has engaged in a collaboration with AAAS and Science magazine, co-funded by the Knut and Alice Wallenberg Foundation, to award an annual prize in the area of life science for the best PhD thesis work.

    The 2016 categories are:
  • Cell and Molecular Biology
  • Ecology and Environment
  • Genomics and Proteomics
  • Translational Medicine
    		•
     
    Termini exhaurit
    ATRESMEDIA
    Potenciar la recerca mèdica de qualitat i la prevenció en salut, a través d'iniciatives de sensibilització i d'accions concretes que impulsin avanços en l'àmbit biomèdic i científic
     
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    The prestigious Pezcoller Foundation–AACR International Award for Cancer Research was established in 1997 to annually recognize a scientist of international renown:
  • who has made a major scientific discovery in basic cancer research OR who has made significant contributions to translational cancer research;
  • who continues to be active in cancer research and has a record of recent, noteworthy publications; and
  • whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.
    The award is intended to honor an individual scientist. However, more than one scientist may be co-nominated and selected to share the award when their investigations are closely related in subject matter and have resulted in work that is worthy of the award.
    		•
     
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    The AACR-CRI Lloyd J. Old Award in Cancer Immunology was established to honor the memory of the late Lloyd J. Old and will recognize an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field.
     
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    This award has been established by the American Association for Cancer Research and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications.
    The AACR Team Science Award will recognize an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or likely will advance our fundamental knowledge of cancer or a team that has applied existing knowledge to advance the detection, diagnosis, prevention or treatment of cancer.
     
    Termini exhaurit
    ARC - Fondation ARC pour la Recherce sur le Cancer
    An annual Prize entitled "Prix Fondation ARC Léopold Griffuel" was created in 1970. The prize is awarded to an investigator or a team, whose work has led to a major breakthrough in cancer research.
     
    Termini exhaurit
    BIOIBÉRICA - BIOIBERICA SA
    Reconèixer aquells projectes o iniciatives innovadores que contribueixin a millorar la gestió de l'artrosi i la qualitat assistencial als pacients, tant en l'àmbit de l'atenció primària com en el de l'atenció hospitalària.
     
    Termini exhaurit
    PSICOFUNDACION - FUNDACIÓN ESPAÑOLA PARA LA PROMOCIÓN Y EL DESARROLLO CIENTÍFICO Y PROFESIONAL DE LA PSICOLOGÍA
    Des de PSICOFUNDACIÓN es pretén aconseguir que sorgeixin idees novedoses tant en la recerca com en l'aplicació pràctica de la ciència psicològica, donant suport a l'esperit emprenedor i innovador dels joves psicòlegs.
     
    Termini exhaurit
    SOCIETAT CATALANA DE CIRURGIA
    Premiar la tasca d'un cirurgià de dins i de fora de l'Estat Espanyol, en reconeixement dels mèrits obtinguts al llarg de la seva vida professional.
     
    Recursos Humans
    Termini exhaurit
    EMBO - THE EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
    The EMBO Long-Term Fellowships support post-doctoral research visits to laboratories throughout Europe and the world. International exchange is a key feature in the application process.
     
    Termini exhaurit
    ARTICULUM
    ARTICULUM is an educational initiative comprising a network of European physicians and centres of excellence in rheumatology, whose aim is to "Promote excellence in information exchange, education, training and disease management in arthritis and pain." ARTICULUM is a non-profit organisation with financial support from Pfizer.

    The ARTICULUM members participating in this Fellowship research programme are based in Europe.
     
     
     
     
    Articles
     
    Manils J, Eduard C, Viña-Vilaseca A, López-Cano M, Diez-Villanueva A, Gómez D, Marruecos L, Ferran M, Benito C, Perrino FW, Vavouri T, de Anta JM, Ciruela F, Soler C*. The exonuclease TREX2 shapes psoriatic phenotype. J Invest Dermatol 2016; 136(12): 2345-2355.
     
    Karachaliou M, Chatzi L, Roumeliotaki T, Kampouri M, Kyriklaki A, Koutra K, Chalkiadaki G, Michel A, Stiakaki E, Kogevinas M, Pawlita M, Waterboer T, de Sanjosé S*. Common infections with polyomaviruses and herpesviruses and neuropsychological development at 4 years of age, the Rhea birth cohort in Crete, Greece. J Child Psychol Psyc 2016; 57(11): 1268-1276.
     
    Alonso-Lana S*, Valentí M, Romaguera A, Sarri C, Sarró S, Rodríguez-Martínez A, Goikolea JM, Amann BL, Maristany T, Salvador R, Vieta E, McKenna PJ, Pomarol-Clotet E. Brain functional changes in first-degree relatives of patients with bipolar disorder: evidence for default mode network dysfunction. Psychol Med 2016; 46(12): 2513-2521.
     
    Hernández-Muñoz I*, Figuerola E, Sanchez-Molina S, Rodríguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Álava E, Mora J*. RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein. Oncotarget 2016; 7(29): 46283-46300.
     
    Alcalde O*, Vallès E, Benito B, Cabrera S, Jiménez-López J, Martí Almor J. Cambios en las propiedades de conducción de las vías accesorias: de preexcitación intermitente a fibrilación auricular preexcitada de riesgo. Rev Esp Cardiol 2016; 69(8): 793-795.
     
     
    López-Botet M*, Muntasell A, Martínez-Rodríguez JE, López-Montañés M, Costa-García M, Pupuleku A. Development of the adaptive NK cell response to human cytomegalovirus in the context aging. Mech Ageing Dev 2016; 158: 23-26.
     
    Arenillas L*, Calvo X, Luño E, Senent L, Alonso E, Ramos F, Ardanaz MT, Pedro C, Tormo M, Marco V, Montoro J, Diez-Campelo M, Brunet S, Arrizabalaga B, Xicoy B, Andreu R, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. J Clin Oncol 2016; 34(27): 3284-3292.
     
    Curigliano G*, Gómez-Pardo P, Meric-Bernstam F, Conte P, Lolkema MP, Beck JT, Bardia A, Martínez-García M, Penault-Llorca F, Dhuria S, Tang Z, Solovieff N, Miller M, Di Tomaso E, Hurvitz SA. Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study. Breast 2016; 28: 191-198.
     
    Gómez-Martin I*, Moreno S, Pujol RM, Segura S. Pigmented fibroepithelioma of Pinkus: A potential dermoscopic simulator of malignant melanoma. J Dermatol 2017; 44(5): 542-543.
     
    Mateu-Jiménez M, Fermoselle C, Rojo F, Mateu de Antonio J, Peña R, Urtreger AJ, Diament MJ, Bal de Kier Joffé ED, Pijuan L, García de Herreros A, Barreiro E*. Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology. Curr Pharm Design 2016; 22(34): 5300-5310.
     
    Barreiro E*. The role of MicroRNAs in COPD muscle dysfunction and mass loss: implications on the clinic. Expert Rev Respir Med 2016; 10(9): 1011-1022.
     
    Albanell J, Molins AB, Martínez LC, López-Muñiz JI, Gil EC, De Juan A, Del Barco S, Pérez YF, Mata JG, Garcia-Palomo A, Gregori JG, Pardo PG, Mañas JJ, Hernández AL, Martínez-de-Dueñas E, Jáñez NM, Murillo SM, Bofill JS, Auñón PZ, Sánchez-Rovira P*. Defining the optimal sequence for the systemic treatment of metastatic breast cancer. Clin Transl Oncol 2017; 19(2): 149-161.
     
    Agulló L*, Buch I, Gutiérrez de Terán H, García-Dorado D, Villà-Freixa J. Computational exploration of the binding mode of heme-dependent stimulators into the active catalytic domain of soluble guanylate cyclase. Proteins 2016; 84(10): 1534-1548.
     
    Arboix A*, Jiménez C, Massons J, Parra O, Besses C. Hematological disorders: a commonly unrecognized cause of acute stroke. Expert Rev Hematol 2016; 9(9): 891-901.
     
    Villanueva V*, Ojeda J, Rocamora R, Serrano-Castro PJ, Parra J, Rodríguez-Uranga JJ, Bathal H, Viteri C. Consenso Delphi EPICON: recomendaciones sobre el manejo adecuado del cambio a acetato de eslicarbazepina en epilepsia. Neurología (Barc) 2018; 33(5): 290-300.
     
    Álvarez N, Díez L, Avellaneda-Gómez C, Serra M, Rubio MA*. Relevancia del síndrome piramidal en la esclerosis lateral amiotrófica. Neurología (Barc) 2018; 33(1): 8-12.
     
    Manzano C, López-Vílchez MA*, Román L, García-García J, Mur Sierra A. Exposición prenatal a metanfetamina «shabú». An Pediatr (Barc) 2017; 86(2): 96-97.
     
     
    Miralpeix E, Solé-Sedeño JM, Mancebo G, Lloveras B, Bellosillo B, Carreras Collado R, Alameda F*. Value of p16(INK4a) and Ki-67 Immunohistochemical Staining in Cervical Intraepithelial Neoplasia Grade 2 Biopsies as Biomarkers for Cervical Intraepithelial Neoplasia Grade 3 in Cone Results. Anal Quant Cytopathol Histpathol 2016; 38: 1-8.
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).